Expert offers perspective on experimental Alzheimer's disease drug
According to drugmakers Eisai and Biogen, a Phase 3 clinical study on a potential new Alzheimer's disease drug shows promise. The study findings show that the drug, lecanemab, reduced clinical decline of people with Alzheimer's ...
Oct 4, 2022
0
4